Edition 02, Frontier AI and Deeptech
November 2025, Elementa, 99 Bishopsgate. Ten frontier AI and deeptech finalists, from carbon capture and hydrogen to RNA therapeutics and operating theatre scheduling, pitched to investors from Amadeus Capital Partners, Riceberg Ventures and SVV. Equisera, then Wild Hydrogen, took Best Overall and Ventrix Labs won both Best Impact and Audience Choice. Finalists SurgeryAI and Unravel Health are now residents of the sclr Venture Hub.





Winners
- Best Overall
Equisera (Wild Hydrogen)- Best Impact
Ventrix Labs- Best Tech Innovation
CamMed (Cambridge Medixine)- Best Path to Profitability
Cardiovolt.ai- Audience Choice
Ventrix Labs
Finalists

Equisera, pitched as Wild Hydrogen. Hydrogen and biomethane from biogenic waste.

Ventrix Labs. Modular carbon capture.

CamMed Therapeutics, pitched as Cambridge Medixine. Self-replicating RNA platform.

Cardiovolt.ai. Heart disease prediction from routine ECGs.

Genosys Bio. ML-designed promoters for biologics manufacturing.

Morpheus Fluid. Meshless fluid simulation.

SurgeryAI. Operating theatre scheduling.

Unravel Health. Saliva-based hormone tracking.

VaprTech. Air conditioning energy control.

Cosignity. Speech and sleep monitoring for cognitive health.
Judges







James Baker (Amadeus Capital Partners), Lino Gandola (Riceberg Ventures), Hunter Moore (Sure Valley Ventures), Andrea Reynolds (Swoop Funding), Thomas Nicolson (Bonham & Brook), Roch Glowacki (Lewis Silkin), Patrycja Maksymowicz (sclr labs).
Partners












































